NETest News

Our liquid biopsy-based NETest is performed at our CLIA-certified clinical laboratory in Branford, CT. Large healthcare organizations have added it to their formulary; below is just some of the recent press coverage.
NETest

NETest shows blood viable for tumor monitoring

Wren Lab’s liquid biopsy has proven an effective biomarker for cancer treatment decision-making.

Read Article
NETest

Blood test predicts NET cancer therapy success

Noninvasive NETest-type diagnostics predict therapy success and provide therapy monitoring.

Read Article
NETest

NETest possible predictor of tumor recurrence

NETest is a highly accurate post-operative predictor of neuroendocrine tumor recurrence.

Read Article